ATLN (Atlantic International Corp. Common Stock) Stock Analysis - News
Atlantic International Corp. Common Stock (ATLN) is a publicly traded Healthcare sector company. As of May 21, 2026, ATLN trades at $1.39 with a market cap of $113.48M and a P/E ratio of -1.22. ATLN moved +0.00% today. Year to date, ATLN is -26.32%; over the trailing twelve months it is -44.88%. Its 52-week range spans $1.16 to $7.97. Rallies surfaces ATLN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in ATLN news today?
Circle8 Netherlands Ranks Fifth with $1.4 B Revenue and 15.2% Growth: Atlantic International's Circle8 Netherlands climbed to #5 in the 2026 Top 100 workforce solutions ranking, generating $1.4 billion in annual gross revenue under Dutch GAAP with 15.2% organic growth. Its framework agreement backlog stands at $3.2 billion, supporting planned AI, cybersecurity and data infrastructure expansion.
Broderick Christopher bought 577.17K (~$57.717) on Jan 7, 2025.
Tenore Michael bought 577.17K (~$57.717) on Jan 7, 2025.
Tenore Michael bought 577.17K (~$57.717) on Jan 7, 2025.
ATLN Analyst Consensus
ATLN analyst coverage data. Average price target: $0.00.
Common questions about ATLN
What changed in ATLN news today?
Circle8 Netherlands Ranks Fifth with $1.4 B Revenue and 15.2% Growth: Atlantic International's Circle8 Netherlands climbed to #5 in the 2026 Top 100 workforce solutions ranking, generating $1.4 billion in annual gross revenue under Dutch GAAP with 15.2% organic growth. Its framework agreement backlog stands at $3.2 billion, supporting planned AI, cybersecurity and data infrastructure expansion.
Does Rallies summarize ATLN news?
Yes. Rallies summarizes ATLN news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is ATLN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ATLN. It does not provide personalized investment advice.